NF-κB is an important player in this multifactorial diseases as evidenced by the fact that the therapeutic efficacy of the main treatment for asthma—glucocorticoids—is thought to be largely caused by their ability to suppress NF-κB and AP-1 responses (52). This evidence concerns the gene NFKB1 and asthma.